Bactec

Device Becton, Dickinson and Company
Total Payments
$35,526
Transactions
37
Doctors
6
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2021 $21,093 1 0
2018 $12,803 31 3
2017 $1,630 5 3

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $21,093 1 59.4%
Education $7,658 27 21.6%
Gift $6,486 3 18.3%
Food and Beverage $290.05 6 0.8%

Payments by Type

Research
$21,093
1 transactions
General
$14,433
36 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Novel Biomarkers to Shorten TB Treatment Becton, Dickinson and Company $21,093 0

Top Doctors Receiving Payments for Bactec

Doctor Specialty Location Total Records
Unknown Rochester, NY $35,236 31
, MD Anatomic Pathology & Clinical Pathology Minneapolis, MN $77.91 1
, MD Pediatric Infectious Diseases Minneapolis, MN $77.91 1
, MD Clinical Pathology/Laboratory Medicine Cleveland, OH $77.90 1
, MD PHD Student in an Organized Health Care Education/Training Program Miami, FL $18.78 1
, M.D Infectious Disease New York, NY $18.78 1
, MD Internal Medicine New York, NY $18.77 1

About Bactec

Bactec is a device associated with $35,526 in payments to 6 healthcare providers, recorded across 37 transactions in the CMS Open Payments database. The primary manufacturer is Becton, Dickinson and Company.

Payment data is available from 2017 to 2021. In 2021, $21,093 was paid across 1 transactions to 0 doctors.

The most common payment nature for Bactec is "Unspecified" ($21,093, 59.4% of total).

Bactec is associated with 1 research study, including "Novel Biomarkers to Shorten TB Treatment" ($21,093).